TrialScientific reports2016

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes.

Xin Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.